Dexcom said Monday that Donald A. Lucas has resigned from its board as well as its audit and compensation committees. Dexcom, of San Diego, develops and markets continuous glucose monitoring systems for ambulatory use. The company has received VC funding from RWI Ventures, Canaan Partners, Federated Kaufman Fund, Fog City Fund, INVESCO, St. Paul Venture Capital, and Windamere Venture Partners. Lucas cofounded RWI.
DexCom, Inc. (NASDAQ:DXCM) today announced that Donald A. Lucas resigned from DexCom’s Board of Directors as well as from its Audit and Compensation Committees.
In announcing the resignation, DexCom President and CEO Terry Gregg said, “Don made many valuable contributions to DexCom’s Board over his eight years of service. His commitment to overseeing the company’s growth far exceeded that of a typical venture capital investor, and he was instrumental in guiding the company’s direction from its beginnings. I am grateful for his significant efforts and am joined by the other directors in wishing him well.”
About DexCom, Inc.
DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.